Oscar Health Inc(OSCR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:52 PM ET (Korea 9/12 08:52)
Full metrics table
| Index | RUT | P/E | 23.93 | EPS (ttm) | 1.37 | Insider Own | 18.58% | Shs Outstand | 273.4M | Perf Week | 1.64% |
| Market Cap | 10.12B | Forward P/E | 17.21 | EPS next Y | 10.45% | Insider Trans | -6.01% | Shs Float | 251.3M | Perf Month | 10.67% |
| Enterprise Value | - | PEG | - | EPS next Q | -0.22 | Inst Own | 61.57% | Short Float | 6.51% | Perf Quarter | 13.35% |
| Income | 0.55B | P/S | 0.66 | EPS this Y | 202.01% | Inst Trans | 8.88% | Short Ratio | 3.01 | Perf Half Y | 152.08% |
| Sales | 15.32B | P/B | 4.93 | EPS next 5Y | - | ROA | 6.4% | Short Interest | 16.36M | Perf YTD | 128.04% |
| Book/sh | 6.65 | P/C | - | EPS past 3/5Y | 16.04% 0.13% | ROE | 34.31% | 52W High | -2.32% ($33.55) | Perf Year | 68.66% |
| Cash/sh | - | P/FCF | 2.31 | Sales past 3/5Y | 43.45% 90.8% | ROIC | 22.17% | 52W Low | 206.55% ($10.69) | Perf 3Y | 398.78% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 364.92% | Gross Margin | - | Volatility(W/M) | 6.11% 5.82% | Perf 5Y | 87.26% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | 42.82% | Oper. Margin | 4.11% | ATR (14) | 1.79 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | 221.42% | Profit Margin | 3.6% | RSI (14) | 58.43 | Recom | 2.54 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.08 | Sales Q/Q | 70.4% | SMA20 | 3.91% ($31.54) | Beta | 2.45 | Target Price | $31.09 |
| Payout | - | Debt/Eq | 0.21 | Earnings | 2026/8/6 | SMA50 | 7.04% ($30.61) | Rel Volume | 1.25 | Prev Close | $32.58 |
| Employees | 2305 | LT Debt/Eq | 0.21 | EPS/Sales Surpr. | 172.95% 1.25% | SMA200 | 57.08% ($20.86) | Avg Volume(3M) | 5.45M | Price | $32.77 |
| IPO | 2021/3/3 | Option/Short | Yes/Yes | Trades | 39849 | Volume | 6,818,028 | Change | 0.58% |
Company
OSCR is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 A U.S. healthcare company that provides technology-driven health insurance. It sells individual marketplace health insurance plans through a digital platform, improves the healthcare service experience, and is a health insurance stock whose performance is tied to member enrollment, the medical loss ratio, and the policy environment.
Over the past 1 year, on the higher side
2% below its 1-year high.
OSCR makes money exceptionally well
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +202.0% this year.
Tap to view numbers
The price looks about right
Trading at 23.9 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Would have changed by +398.8% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 61.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
MNVT 0.06%
HEAL 0.05%
EKG 0.04%
ABLS 0.04%
TCV 0.04%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
OSCX 9MIt ranks #4 in the industry
Based on market cap of $10B.
OSCR $10B PER 23.9
UNH $340B PER 24.4
CVS $121B PER 25.0
ELV $91B PER 18.6
FAQ
What kind of company is OSCR?
OSCR belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of OSCR?
The market cap of OSCR is approximately $10.1B, ranking 936 within its sector.
What is the P/E ratio of OSCR?
OSCR has a P/E ratio of approximately 23.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for OSCR?
OSCR has recorded a 52-week high of $33.55 and a low of $10.69.
